| 2000-12 | 6-hydroxy-1,3-dioxin-4-ones as non-peptidic HIV protease inhibitors | Lee, YS; Lee, YS; Lee, JY; Kim, SN; Lee, CK; Park, H |
| 2000-01 | Characterization of epidermal growth factor receptor function in lysophosphatidic acid signaling in PC12 cells | Kim, SN; Park, JG; Lee, EB; Kim, SS; Yoo, YS |
| 1999-12 | Chiral synthesis of trans-1-aminoindolo[2,3-a] quinolizidine and trans-1-aminobenzo[a]quinolizidine derivatives from L-pyroglutamic acid | Lee, YS; Cho, DJ; Kim, SN; Choi, JH; Park, H |
| 2001-06 | Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors | Hwang, DJ; Kim, SN; Choi, JH; Lee, YS |
| 2000-10 | Synthesis and HIV protease inhibitory activity of new 4-hydroxy-2-pyrone derivatives | Lee, YS; Kim, SN; Lee, YS; Lee, JY; Lee, CK; Kim, HS; Park, H |
| 2000-08 | Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides | Kim, SN; Lee, JY; Kim, HJ; Shin, CG; Park, H; Lee, YS |
| 2006-01-01 | The structure-activity relationships of mansonone F, a potent anti-MRSA sesquiterpenoid quinone: SAR studies on the C6 and C9 analogs | Suh, YG; Kim, SN; Shin, DY; Hyun, SS; Lee, DS; Min, KH; Han, SM; Li, FN; Choi, EC; Choi, SH |
| 2001-07 | Two sulfonamides-containing dihydropyrone derivatives as HIV protease inhibitors | Lee, JY; Kim, SN; Lee, CK; Park, H; Lee, YS |
